company background image
531599

FDC BSE:531599 Stock Report

Last Price

₹256.60

Market Cap

₹42.6b

7D

0.7%

1Y

-12.9%

Updated

03 Feb, 2023

Data

Company Financials +

531599 Stock Overview

FDC Limited manufactures and markets pharmaceutical products in India and internationally.

531599 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

FDC Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for FDC
Historical stock prices
Current Share Price₹256.60
52 Week High₹319.00
52 Week Low₹229.15
Beta0.21
1 Month Change-5.47%
3 Month Change-16.06%
1 Year Change-12.88%
3 Year Change7.05%
5 Year Change-10.33%
Change since IPO5,902.34%

Recent News & Updates

Recent updates

Shareholder Returns

531599IN PharmaceuticalsIN Market
7D0.7%-1.2%-1.1%
1Y-12.9%-8.1%-3.4%

Return vs Industry: 531599 underperformed the Indian Pharmaceuticals industry which returned -8.7% over the past year.

Return vs Market: 531599 underperformed the Indian Market which returned -4.1% over the past year.

Price Volatility

Is 531599's price volatile compared to industry and market?
531599 volatility
531599 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.4%

Stable Share Price: 531599 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 531599's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19366,336Nandan Chandavarkarhttps://www.fdcindia.com

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names.

FDC Limited Fundamentals Summary

How do FDC's earnings and revenue compare to its market cap?
531599 fundamental statistics
Market Cap₹42.57b
Earnings (TTM)₹1.69b
Revenue (TTM)₹16.22b

25.2x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
531599 income statement (TTM)
Revenue₹16.22b
Cost of Revenue₹6.23b
Gross Profit₹9.99b
Other Expenses₹8.31b
Earnings₹1.69b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 09, 2023

Earnings per share (EPS)10.17
Gross Margin61.59%
Net Profit Margin10.40%
Debt/Equity Ratio0.03%

How did 531599 perform over the long term?

See historical performance and comparison